The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients
Clinical trial NCT01770483 · COMPLETED
Trial details
- NCT number
- NCT01770483
- Sponsor
- Services Institute of Medical Sciences, Pakistan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.